Suppr超能文献

新型精神药物制剂美比卡的药理作用

[Pharmacological effects of the new psychotropic preparation, mebikar].

作者信息

Zimakova I E

出版信息

Farmakol Toksikol. 1977 Nov-Dec;40(6):684-7.

PMID:598490
Abstract

By its effects mebicar -- a derivative of bicyclic bis-ureas -- may be refered to psychotropic drugs occupying a middle position between tranquilizers and neuroleptics. The drug inhibits the orientation reaction in albino mice, potentiates the action of narcotic hypnotics, abolishes the conditioned reflex reaction of avoidance, displays central adrenolytic activity, interferes with the norepinephrine metabolism in the brain stem and modifies the permeability of the blood-encephalic barrier, like this is done by the known neuroleptics. The substance is little toxic, does not exert any direct spasmolytic action on the isolated organs.

摘要

通过其作用,美比卡(一种双环双脲衍生物)可被归类为精神药物,处于镇静剂和神经阻滞剂之间的中间位置。该药物抑制白化小鼠的定向反应,增强麻醉性催眠药的作用,消除回避条件反射反应,表现出中枢性肾上腺能阻断活性,干扰脑干中的去甲肾上腺素代谢,并改变血脑屏障的通透性,就像已知的神经阻滞剂那样。该物质毒性很小,对离体器官没有任何直接的解痉作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验